Avitar, Inc. (AVTI) Research

Avitar, Inc., a holding company established in 1986, leverages its subsidiaries to develop, produce, and market a diverse array of diagnostic testing solutions and specialized hydrophilic polyurethane foam disposable goods. These products cater to various applications within the medical, diagnostic, dental, and consumer sectors throughout the United States. Among its diagnostic offerings are the ORALscreen 4 and ORALscreen DRUGOMETER, which are oral fluid-based rapid assay systems. These are designed to identify a range of illicit substances, including opiates such as heroin, morphine, codeine, and synthetic versions like oxycodone-oxycontin, percoset, and hydrocodone-vicodin, as well as cocaine (including crack), marijuana, and methamphetamines (such as crystal meth and ecstasy). Furthermore, Avitar manufactures medical-grade hydrophilic polyurethane foam disposables. This category features wound dressings like Hydrasorb, specifically designed for exudating wounds, alongside custom foam items such as a sinus dressing and an ingenious device used by astronauts to alleviate ear pressure in pressurized space suits. The company also innovates specialty wound dressings for cardiac catheterization labs and the Illizarov Dressing, employed for external bone fixators in orthopedic surgeries. Avitar disseminates its products and services to a broad client base, including employers, diagnostic test distributors, medical supply firms, government entities, educational institutions, and other corporations, utilizing a combination of its direct sales team, strategic alliances, and an extensive distribution network. The company is headquartered in Canton, Massachusetts, and maintains an additional office in Calgary, Canada.

Open Avitar, Inc. (AVTI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.